Spatially Controlled Capture and Site-Resolved Analysis of Single Extracellular Vesicles.
Quantitative fluorescence analysis of single extracellular vesicles (EVs) is often complicated by heterogeneous particle loading on continuous surfaces, obscuring where and how a signal should be coun
APA
Lee JB, Conteduca D, et al. (2026). Spatially Controlled Capture and Site-Resolved Analysis of Single Extracellular Vesicles.. Small (Weinheim an der Bergstrasse, Germany), e14514. https://doi.org/10.1002/smll.202514514
MLA
Lee JB, et al.. "Spatially Controlled Capture and Site-Resolved Analysis of Single Extracellular Vesicles.." Small (Weinheim an der Bergstrasse, Germany), 2026, pp. e14514.
PMID
41999595
Abstract
Quantitative fluorescence analysis of single extracellular vesicles (EVs) is often complicated by heterogeneous particle loading on continuous surfaces, obscuring where and how a signal should be counted. This study presents a simple, array-based method that couples site-specific capture into optically resolvable nanowells with mask-gated image analysis to obtain unambiguous, single-site fluorescence measurements. EVs settle onto nanowell arrays, and excess particles on the inter-well surface are cleared by a PDMS translation step, resulting in the capture of single EVs in discrete nanowells and accurate detection of in-well signals that are registered to a bright-field nanowell mask. This format yields > 99% EV capture at the designed location in grids and enables the accurate detection of EVs' fluorescence signals with a low background. Compositional analysis on a single substrate accurately tracks programmed EV mixture ratios with near-unity slopes and HER2 positivity in breast cancer EVs. Finally, the patterning method is readily adapted to plasma-derived EVs, expanded to multi-channel fluorescence imaging, and applied to mixed cargos of co-patterned EVs and nanoparticles. These results establish a reliable pathway for array-based EV detection and precise manipulations of EVs and other nanoparticles.
같은 제1저자의 인용 많은 논문 (4)
- A Phase 2 Study of Stereotactic Ablative Radiotherapy Plus Atezolizumab Plus Tiragolumab in Treatment-naïve Patients with Advanced Non-small Cell Lung Cancer.
- Lazertinib with stereotactic body radiotherapy in oligometastatic EGFR-mutant non-small-cell lung cancer.
- Corrigendum to 'Lazertinib with stereotactic body radiotherapy in oligometastatic EGFR-mutant non-small-cell lung cancer': [ESMO Open. Volume 11, Issue 2, February 2026, 106057].
- Lower facial contouring surgery using a novel method: M-genioplasty.